Long pentraxin 3 as a marker of COVID-19 severity: evidences and perspectives

INTRODUCTION: Several laboratory tests are characteristically altered in Coronavirus Disease 2019 (COVID-19), but are not totally accurate in predicting the disease outcome. The long pentraxin 3 (PTX3) is quickly released directly at inflammation sites by many immune cell types. Previous studies hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Assandri, Roberto, Accordino, Silvia, Canetta, Ciro, Buscarini, Elisabetta, Scartabellati, Alessandro, Tolassi, Chiara, Serana, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Croatian Society of Medical Biochemistry and Laboratory Medicine 2022
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996318/
https://www.ncbi.nlm.nih.gov/pubmed/35464745
http://dx.doi.org/10.11613/BM.2022.020901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996318/
https://www.ncbi.nlm.nih.gov/pubmed/35464745
http://dx.doi.org/10.11613/BM.2022.020901

Ejemplares similares